HRP20161792T1 - Sojevi bifidobacterium bifiduma za primjenu u gastrointestinalnim bolestima - Google Patents
Sojevi bifidobacterium bifiduma za primjenu u gastrointestinalnim bolestima Download PDFInfo
- Publication number
- HRP20161792T1 HRP20161792T1 HRP20161792TT HRP20161792T HRP20161792T1 HR P20161792 T1 HRP20161792 T1 HR P20161792T1 HR P20161792T T HRP20161792T T HR P20161792TT HR P20161792 T HRP20161792 T HR P20161792T HR P20161792 T1 HRP20161792 T1 HR P20161792T1
- Authority
- HR
- Croatia
- Prior art keywords
- probiotic formulation
- powder
- food product
- tablet
- strain
- Prior art date
Links
- 241000186016 Bifidobacterium bifidum Species 0.000 title claims 2
- 229940002008 bifidobacterium bifidum Drugs 0.000 title claims 2
- 208000018522 Gastrointestinal disease Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 claims 12
- 238000009472 formulation Methods 0.000 claims 11
- 239000006041 probiotic Substances 0.000 claims 11
- 235000018291 probiotics Nutrition 0.000 claims 11
- 230000000529 probiotic effect Effects 0.000 claims 10
- 235000013305 food Nutrition 0.000 claims 6
- 239000000843 powder Substances 0.000 claims 6
- 239000002775 capsule Substances 0.000 claims 5
- 150000001720 carbohydrates Chemical class 0.000 claims 3
- 235000014633 carbohydrates Nutrition 0.000 claims 3
- 239000000126 substance Substances 0.000 claims 3
- 235000013343 vitamin Nutrition 0.000 claims 3
- 239000011782 vitamin Substances 0.000 claims 3
- 229940088594 vitamin Drugs 0.000 claims 3
- 229930003231 vitamin Natural products 0.000 claims 3
- 206010012735 Diarrhoea Diseases 0.000 claims 2
- 229920001202 Inulin Polymers 0.000 claims 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims 2
- 229940029339 inulin Drugs 0.000 claims 2
- 208000002551 irritable bowel syndrome Diseases 0.000 claims 2
- 235000013336 milk Nutrition 0.000 claims 2
- 239000008267 milk Substances 0.000 claims 2
- 210000004080 milk Anatomy 0.000 claims 2
- 235000010755 mineral Nutrition 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 235000013618 yogurt Nutrition 0.000 claims 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims 1
- 208000004998 Abdominal Pain Diseases 0.000 claims 1
- 206010000060 Abdominal distension Diseases 0.000 claims 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 1
- 241000193163 Clostridioides difficile Species 0.000 claims 1
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 206010010774 Constipation Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims 1
- 239000004375 Dextrin Substances 0.000 claims 1
- 229920001353 Dextrin Polymers 0.000 claims 1
- 229930091371 Fructose Natural products 0.000 claims 1
- 239000005715 Fructose Substances 0.000 claims 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 1
- 229920002774 Maltodextrin Polymers 0.000 claims 1
- 239000005913 Maltodextrin Substances 0.000 claims 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims 1
- 229930195725 Mannitol Natural products 0.000 claims 1
- 208000002389 Pouchitis Diseases 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims 1
- 208000024330 bloating Diseases 0.000 claims 1
- 239000011575 calcium Substances 0.000 claims 1
- 229910052791 calcium Inorganic materials 0.000 claims 1
- 235000013351 cheese Nutrition 0.000 claims 1
- 206010009887 colitis Diseases 0.000 claims 1
- 239000012141 concentrate Substances 0.000 claims 1
- 235000013365 dairy product Nutrition 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- 235000019425 dextrin Nutrition 0.000 claims 1
- 239000008121 dextrose Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 201000006549 dyspepsia Diseases 0.000 claims 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims 1
- 229940107187 fructooligosaccharide Drugs 0.000 claims 1
- 229930195712 glutamate Natural products 0.000 claims 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 1
- 230000000968 intestinal effect Effects 0.000 claims 1
- 239000008101 lactose Substances 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 239000011777 magnesium Substances 0.000 claims 1
- 229910052749 magnesium Inorganic materials 0.000 claims 1
- 229940035034 maltodextrin Drugs 0.000 claims 1
- 239000000594 mannitol Substances 0.000 claims 1
- 235000010355 mannitol Nutrition 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- 239000002366 mineral element Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 239000000600 sorbitol Substances 0.000 claims 1
- 235000021262 sour milk Nutrition 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 239000011573 trace mineral Substances 0.000 claims 1
- 235000013619 trace mineral Nutrition 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Nutrition Science (AREA)
- Rheumatology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Transplantation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11000744.0A EP2481299B1 (en) | 2011-01-31 | 2011-01-31 | Bifidobacterium bifidum strains for application in gastrointestinal diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20161792T1 true HRP20161792T1 (hr) | 2017-03-10 |
Family
ID=43901563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20161792TT HRP20161792T1 (hr) | 2011-01-31 | 2016-12-28 | Sojevi bifidobacterium bifiduma za primjenu u gastrointestinalnim bolestima |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9408879B2 (enExample) |
| EP (1) | EP2481299B1 (enExample) |
| JP (1) | JP5956467B2 (enExample) |
| CN (1) | CN103476273A (enExample) |
| AU (1) | AU2012213576B2 (enExample) |
| BR (1) | BR112013019258B1 (enExample) |
| CA (1) | CA2825980C (enExample) |
| DK (1) | DK2481299T3 (enExample) |
| ES (1) | ES2610908T3 (enExample) |
| HR (1) | HRP20161792T1 (enExample) |
| HU (1) | HUE033189T2 (enExample) |
| PL (1) | PL2481299T3 (enExample) |
| PT (1) | PT2481299T (enExample) |
| RU (1) | RU2603285C2 (enExample) |
| WO (1) | WO2012104226A1 (enExample) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
| GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
| GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
| CN103266076B (zh) * | 2013-06-04 | 2014-10-29 | 神舟太空产品高科技成果推广中心集团有限公司 | 太空诱变高效两歧双歧杆菌、其应用及其胶囊制剂的制备方法 |
| CN104546945A (zh) * | 2014-09-30 | 2015-04-29 | 深圳华大基因科技有限公司 | 两歧双歧杆菌在治疗或预防类风湿性关节炎或其相关疾病中的用途 |
| KR20170091157A (ko) | 2014-12-23 | 2017-08-08 | 4디 파마 리서치 리미티드 | 피린 폴리펩티드 및 면역 조정 |
| PL3065748T3 (pl) | 2014-12-23 | 2018-07-31 | 4D Pharma Research Limited | Szczep Bacteroides thetaiotaomicron i jego zastosowanie w zmniejszaniu zapalenia |
| CN107567333A (zh) * | 2015-03-09 | 2018-01-09 | 生物免疫Sagl公司 | 包含抗氧化剂与双歧杆菌和从益生菌分离的细胞壁的抗衰老组合物 |
| MA41010B1 (fr) | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| MD3650033T2 (ro) | 2015-06-15 | 2022-08-31 | 4D Pharma Res Ltd | Compoziții conţinând tulpini bacteriene |
| EA201890050A1 (ru) | 2015-06-15 | 2018-06-29 | 4Д Фарма Рисёрч Лимитед | Композиции, содержащие бактериальные штаммы |
| SI3240554T1 (sl) | 2015-06-15 | 2019-12-31 | 4D Pharma Research Limited, | Blautia stercosis in wexlerae za uporabo v zdravljenju vnetnih in avtoimunskih bolezni |
| MA41060B1 (fr) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| JP6637725B2 (ja) * | 2015-10-28 | 2020-01-29 | ビオフェルミン製薬株式会社 | ウイルス感染症の予防及び／又は治療剤 |
| AU2016357554B2 (en) | 2015-11-20 | 2019-04-04 | Cj Bioscience, Inc. | Compositions comprising bacterial strains |
| GB201520497D0 (en) | 2015-11-20 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| GB201520638D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| GB201520631D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| GB201612191D0 (en) | 2016-07-13 | 2016-08-24 | 4D Pharma Plc | Compositions comprising bacterial strains |
| EP3520801A1 (en) | 2016-03-04 | 2019-08-07 | 4D Pharma Plc | Compositions comprising bacterial blautia strains for treating visceral hypersensitivity |
| CA3020389A1 (en) * | 2016-04-14 | 2017-10-19 | Dupont Nutrition Biosciences Aps | Bifidobacteria for increasing lean body mass |
| TW201821093A (zh) | 2016-07-13 | 2018-06-16 | 英商４Ｄ製藥有限公司 | 包含細菌菌株之組合物 |
| GB201621123D0 (en) | 2016-12-12 | 2017-01-25 | 4D Pharma Plc | Compositions comprising bacterial strains |
| CN106579414A (zh) * | 2016-12-26 | 2017-04-26 | 北京康比特体育科技股份有限公司 | 一种缓解运动性腹泻的组合物 |
| CN106834187B (zh) * | 2017-03-06 | 2020-08-25 | 江南大学 | 一种两歧双歧杆菌及其用途 |
| WO2018165563A1 (en) * | 2017-03-09 | 2018-09-13 | The Clorox Company | Probiotic capsule and methods of preparing the same |
| JP2018177703A (ja) * | 2017-04-14 | 2018-11-15 | 株式会社明治 | Ｔｏｌｌ様受容体２活性化用組成物 |
| JP7212945B2 (ja) | 2017-05-22 | 2023-01-26 | フォーディー ファーマ リサーチ リミテッド | 細菌株を含む組成物 |
| TW201907931A (zh) | 2017-05-24 | 2019-03-01 | 英商4D製藥研究有限公司 | 包含細菌菌株之組合物 |
| CN115813955A (zh) | 2017-06-14 | 2023-03-21 | 4D制药研究有限公司 | 包含细菌菌株的组合物 |
| WO2018229188A1 (en) | 2017-06-14 | 2018-12-20 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
| MD3804737T2 (ro) | 2017-06-14 | 2022-10-31 | 4D Pharma Res Limited | Compoziții care conțin tulpini bacteriene |
| KR20250021602A (ko) * | 2018-01-29 | 2025-02-13 | 프리시젼바이오틱스 그룹 리미티드 | 과민성 대장 증후군의 예방 및 치료를 위한 조합 생성물 |
| KR102023700B1 (ko) * | 2018-01-31 | 2019-09-20 | 주식회사 비피도 | 비피도박테리움을 함유한 류마티스관절염 개선용, 치료용 또는 예방용 조성물 |
| US20210268041A1 (en) * | 2018-06-22 | 2021-09-02 | Synformulas Gmbh | Non-viable bifidobacterium bifidum bacteria and uses thereof |
| PL3911341T3 (pl) * | 2019-01-16 | 2023-05-02 | N.V. Nutricia | Fermentowany preparat z nieulegającymi trawieniu oligosacharydami do zastosowania w zakażeniu wywołanym przez rotawirusy |
| IT201900011193A1 (it) * | 2019-07-08 | 2021-01-08 | Sofar Spa | Ceppo di batteri Bifidobacterium bifidum, sue composizioni e relativi usi |
| US20220331376A1 (en) * | 2019-09-05 | 2022-10-20 | White Dog Labs | Mixotrophic probiotic compositions and uses thereof in the treatment of bloating |
| IT201900016811A1 (it) * | 2019-09-20 | 2021-03-20 | Sofar Spa | Ceppi batterici, loro composizioni e loro uso per il trattamento di disturbi gastrointestinali |
| CN118924795A (zh) * | 2019-11-29 | 2024-11-12 | 内蒙古伊利实业集团股份有限公司 | 乳双歧杆菌bl-99提升肠道细菌感染抗性和肠道免疫力的应用 |
| CN111110704B (zh) * | 2020-02-14 | 2023-03-28 | 上海城建职业学院 | 一种益生菌菌剂、滴剂及其制备方法和应用 |
| CN111743998A (zh) * | 2020-06-04 | 2020-10-09 | 中通美雅生命健康(深圳)有限公司 | 用于辅助治疗肠炎组合物及其制备方法 |
| RU2735717C1 (ru) * | 2020-06-15 | 2020-11-06 | Общество с ограниченной ответственностью "АВАН" | Штамм Bifidobacterium bifidum, используемый в качестве пробиотика |
| WO2022065848A1 (ko) * | 2020-09-23 | 2022-03-31 | 피비엘바이오랩 주식회사 | 신규 유산균 및 이의 용도 |
| CN113943682B (zh) * | 2020-11-12 | 2023-07-04 | 江南大学 | 缓解便秘的长双歧杆菌长亚种及其制备的发酵食品与益生菌制剂 |
| EP4243796A4 (en) * | 2020-11-16 | 2025-01-22 | Orcosa Inc. | IMPROVED USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY |
| US11672761B2 (en) | 2020-11-16 | 2023-06-13 | Orcosa Inc. | Rapidly infusing platform and compositions for therapeutic treatment in humans |
| CN113025526B (zh) * | 2021-03-24 | 2022-09-27 | 江南大学 | 一株减少结肠病理损伤且具有缓解便秘作用的两歧双歧杆菌 |
| CN112980734B (zh) * | 2021-03-24 | 2022-07-22 | 江南大学 | 一株缓解便秘并调节肠道菌群紊乱的两歧双歧杆菌及其应用 |
| CN113234619B (zh) * | 2021-04-10 | 2022-07-05 | 江南大学 | 一株两歧双歧杆菌及其在缓解肠道损伤中的应用 |
| CN116286439A (zh) * | 2022-07-13 | 2023-06-23 | 四川大学 | 一株婴幼儿肠道来源的两歧双歧杆菌及应用 |
| CN118291322A (zh) * | 2022-07-13 | 2024-07-05 | 四川大学 | 一株婴幼儿肠道来源的两歧双歧杆菌 |
| CN115838662A (zh) * | 2022-11-02 | 2023-03-24 | 江南大学 | 一株具有缓解克罗恩病潜力的两歧双歧杆菌 |
| EP4631511A4 (en) * | 2023-03-21 | 2026-04-22 | Sichuan Anaerobic Biotechnology Co Ltd | PROBIOTICS AND THEIR USE |
| CN118044616A (zh) * | 2023-09-05 | 2024-05-17 | 厦门大学 | 一种合生元及其用途 |
| WO2025059424A1 (en) * | 2023-09-15 | 2025-03-20 | Biohm Health Inc. | Pro-biotic compositions and methods for treatment of stress |
| CN118879582B (zh) * | 2024-09-19 | 2025-03-25 | 微康益生菌(苏州)股份有限公司 | 一种细胞完整、分散均匀、稳定性强的后生元制备方法 |
| CN121102165A (zh) * | 2025-11-13 | 2025-12-12 | 厦门承葛生物科技有限公司 | 用于精准肠道菌群移植的肠道菌群胶囊及其制备方法和应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ID29150A (id) | 1999-01-15 | 2001-08-02 | Entpr Ireland Cs | Penggunaan lactobacillus salivarius |
| RU2152993C1 (ru) * | 1999-11-30 | 2000-07-20 | Государственный научный центр РФ Институт медико-биологических проблем | Штамм bifidobacterium bifidum вкпм ас-1578, используемый для приготовления бактериальных препаратов и продуктов питания |
| RU2184146C1 (ru) * | 2001-01-29 | 2002-06-27 | Закрытое акционерное общество "Партнер" | Штамм bifidobacterium bifidum 45 вкпм ас-1621, используемый для приготовления бактериальных препаратов и продуктов питания |
| MXPA05010349A (es) * | 2003-06-30 | 2006-03-08 | Clasado Inc | Composicion novedosa de galactooligosacaridos y preparacion de la misma. |
| BRPI0418986A (pt) * | 2004-08-05 | 2007-12-11 | Anidral Srl | cepas bacterianas bifidobacterium produtoras de ácido fólico, formulações e seus usos |
| PL1885383T3 (pl) * | 2005-05-31 | 2017-06-30 | Iams Europe B.V. | Kocie probiotyczne bifidobakterie |
| CN100490826C (zh) * | 2005-07-05 | 2009-05-27 | 广州市微生物研究所 | 多联活性双歧杆菌产品的制备方法 |
| JP4881304B2 (ja) * | 2005-07-21 | 2012-02-22 | 株式会社ヤクルト本社 | 新規ビフィドバクテリウム属細菌及びその利用 |
| US9084434B2 (en) * | 2006-09-27 | 2015-07-21 | Little Calumet Holdings Llc | Probiotic oral dosage forms |
| RU2009133376A (ru) * | 2007-03-27 | 2011-05-10 | Дзе Проктер Энд Гэмбл Компани (US) | Способы и наборы для введения пробиотиков |
| DK2270133T3 (en) * | 2008-04-22 | 2015-09-07 | Corporación Alimentaria Peñasanta Capsa | Method of obtaining a new strain of Bifidobacterium bidifum with effect against infection with Helicobacter pylori |
| EP2280713A1 (en) * | 2008-05-01 | 2011-02-09 | The Procter & Gamble Company | Methods and kits for the treatment of inflammatory bowel disorder conditions |
| EP2285387B1 (en) * | 2008-06-13 | 2015-10-14 | N.V. Nutricia | Nutrition for prevention of infections |
-
2011
- 2011-01-31 HU HUE11000744A patent/HUE033189T2/en unknown
- 2011-01-31 PT PT110007440T patent/PT2481299T/pt unknown
- 2011-01-31 ES ES11000744.0T patent/ES2610908T3/es active Active
- 2011-01-31 PL PL11000744T patent/PL2481299T3/pl unknown
- 2011-01-31 DK DK11000744.0T patent/DK2481299T3/en active
- 2011-01-31 EP EP11000744.0A patent/EP2481299B1/en active Active
-
2012
- 2012-01-27 JP JP2013550895A patent/JP5956467B2/ja active Active
- 2012-01-27 WO PCT/EP2012/051369 patent/WO2012104226A1/en not_active Ceased
- 2012-01-27 AU AU2012213576A patent/AU2012213576B2/en active Active
- 2012-01-27 CN CN2012800125218A patent/CN103476273A/zh active Pending
- 2012-01-27 CA CA2825980A patent/CA2825980C/en active Active
- 2012-01-27 US US13/982,932 patent/US9408879B2/en active Active
- 2012-01-27 BR BR112013019258-5A patent/BR112013019258B1/pt active IP Right Grant
- 2012-01-27 RU RU2013137404/10A patent/RU2603285C2/ru active
-
2016
- 2016-12-28 HR HRP20161792TT patent/HRP20161792T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2825980C (en) | 2017-10-24 |
| CN103476273A (zh) | 2013-12-25 |
| EP2481299A1 (en) | 2012-08-01 |
| EP2481299B1 (en) | 2016-12-07 |
| HUE033189T2 (en) | 2017-11-28 |
| JP5956467B2 (ja) | 2016-07-27 |
| BR112013019258B1 (pt) | 2021-09-08 |
| RU2603285C2 (ru) | 2016-11-27 |
| PL2481299T3 (pl) | 2017-09-29 |
| WO2012104226A1 (en) | 2012-08-09 |
| PT2481299T (pt) | 2017-03-08 |
| CA2825980A1 (en) | 2012-08-09 |
| NZ613544A (en) | 2014-10-31 |
| BR112013019258A2 (pt) | 2016-10-11 |
| JP2014505065A (ja) | 2014-02-27 |
| AU2012213576B2 (en) | 2015-07-23 |
| BR112013019258A8 (pt) | 2017-09-19 |
| DK2481299T3 (en) | 2017-02-06 |
| RU2013137404A (ru) | 2015-03-10 |
| ES2610908T3 (es) | 2017-05-04 |
| US20140056852A1 (en) | 2014-02-27 |
| US9408879B2 (en) | 2016-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014505065A5 (enExample) | ||
| Bertazzoni et al. | Probiotics and clinical effects: is the number what counts? | |
| KR102606971B1 (ko) | 생애 초기에 미생물총 불균형을 회복하기 위한 l. 루테리의 용도 | |
| RU2013137404A (ru) | Штаммы bifidobacterium bifidum для применения при заболеваниях желудочно-кишечного тракта | |
| EP2700412A1 (en) | PROBIOTICS, SECRETORY IgA AND INFLAMMATION | |
| JP2018536427A5 (enExample) | ||
| RU2018119287A (ru) | Бифидобактерии лонгум для лечения ожирения и связанных с ним метаболических нарушений | |
| CN110393728A (zh) | 乳酸杆菌属、其医药组合物及可食用组合物于治疗、预防或改善骨质疾病的用途 | |
| ES2604136T3 (es) | Composición que comprende proteínas lácteas termolábiles y proceso para la preparación de la misma | |
| JPWO2017110988A1 (ja) | ゲル状食品組成物 | |
| ES2763350B2 (es) | Cepa de christensenella minuta y uso de la misma | |
| CN104207146A (zh) | 呼吸系统疾病全营养配方食品 | |
| CN102088981B (zh) | 帮助唾液分泌的唾液酸 | |
| CN104223057A (zh) | 肝病全营养配方食品 | |
| CN104161263B (zh) | 儿童全营养配方食品 | |
| CN105361146A (zh) | 一种肝病患者食用的全营养特殊配方食品 | |
| CN105029393A (zh) | 儿童医学配方食品 | |
| CN104256633A (zh) | 妇女延更调理全营养配方食品 | |
| CN111201026B (zh) | 具有癌性恶病质抑制作用的发酵乳和多糖类 | |
| CN108618140A (zh) | 孕妇产前调理医学配方食品 | |
| MX2010012254A (es) | Acido sialico para apoyar el sistema inmunologico en la vejez. | |
| CN104839685A (zh) | 创伤感染手术及其它应急状态医学配方食品 | |
| JP2019081733A5 (enExample) | ||
| Chauhan et al. | Probiotic, prebiotic and synbiotics in the prevention of lifestyle disorders | |
| TWI745454B (zh) | 抑制腸道內乳桿菌屬乳酸菌減少用之組成物 |